#PatentLaw #PharmaIP #Semaglutide #DelhiHighCourt #IPStrategy #GenericDrugs #LifeSciences To view or add a comment, sign in There were 46 new drug (NDA or BLA) approvals in 2025, "...well above the historic average, of 36 new drugs per year since 1993." To view or add a comment, sign in Based on TennCare s Drug Utilization Review, an estimated $328 million is spent annually on psychotropic drugsa 5.6% increase over 2024
Common GLP-1 injection include Exenatide, the first approved GLP-1 receptor agonist that requires twice daily or once weekly injections (long-acting formulation) Liraglutide, It is injected once a day to treat type 2 diabetes and obesity
It is not advice to evade legitimate testing programs
Scientific & Chemical Identification CAS Number: 121062-08-6 Molecular Formula: CHNO Molecular Weight (M.W.): ~1024.18 g/mol Amino Acid Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH Synonyms: Melanotan II, MT-II Peptide Mechanism & Receptor Activity Melanotan-II acts as a non-selective agonist at melanocortin receptors (MC1R, MC3R, MC4R, and MC5R) , mimicking certain effects of endogenous -MSH in research models
Baev AY, Vinokurov AY, Novikova IN, Dremin VV, Potapova EV, Abramov AY
